
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1341 | 1104 | 1341 | 1253 | 1802 | 2951 |
Fund Return | 34.12% | 10.36% | 34.12% | 7.82% | 12.49% | 11.43% |
Place in category | 538 | 618 | 538 | 577 | 384 | 144 |
% in Category | 27 | 26 | 27 | 35 | 28 | 21 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Institutional Fund 2 EquiP2X | 8.29B | 0.98 | 11.71 | 12.36 | ||
UBS CH Institutional Fund 2 EquiPAX | 4.34B | 2.19 | 10.23 | 9.88 | ||
UBS CH Vitainvest 50 World U | 4.27B | 7.32 | -1.50 | 2.35 | ||
UBS CH Institutional Fund 2 EquiSCA | 2.93B | 3.61 | 3.69 | 7.88 | ||
UBS CH Institutional Fund 2 EquiSCX | 2.93B | -0.41 | 2.98 | 6.78 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Institutional Fund 2 EquiP2X | 8.29B | 0.98 | 11.71 | 12.36 | ||
Aktien USA Passiv CHF A1 | 2.04B | 0.95 | 11.58 | 12.15 | ||
Aktien USA Passiv CHF D3 | 2.04B | 0.88 | 11.02 | 11.52 | ||
Aktien USA Passiv CHF E3 | 2.04B | 0.83 | 10.69 | 11.22 | ||
UBS CH Institutional Fund 2 EquUSAA | 1.9B | 0.95 | 11.48 | 12.13 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 7.34 | 217.90 | -2.66% | |
NVIDIA | US67066G1040 | 6.35 | 109.67 | -1.58% | |
Microsoft | US5949181045 | 5.74 | 378.80 | -3.02% | |
Amazon.com | US0231351067 | 4.00 | 192.72 | -4.29% | |
Meta Platforms | US30303M1027 | 2.47 | 576.74 | -4.29% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Neutral | Buy |
Technical Indicators | BUY | Strong Sell | Strong Buy |
Summary | Neutral | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review